11 |
Myocardial energy transduction in the isolated working rat heartKeon, Claudia Anne January 1997 (has links)
No description available.
|
12 |
Synthesis of 5 thioglucose derivatives in the carbohydrate metabolic pathways in lactic acid bacteriaYang, Min January 2003 (has links)
No description available.
|
13 |
Glycolysis in Crithidia fasciculataHale, R. D. January 1987 (has links)
No description available.
|
14 |
AMP-activated protein kinase and hypertrophic remodeling of heart muscle cellsSaeedi, Ramesh 05 1900 (has links)
Introduction: Cardiac hypertrophy is an adaptive response to increased myocardial workload that becomes maladaptive when hypertrophied hearts are exposed to an acute metabolic stress, such as ischemia/reperfusion. Acceleration of glycolysis occurs as part of the hypertrophic response and may be maladaptive because it enhances glycolytic metabolite accumulation and proton production. Activation of AMP-activated protein kinase (AMPK), a kinase involved in the regulation of energy metabolism, is proposed as a mechanism for the acceleration of glycolysis in hypertrophied hearts. However, this concept has not yet been proven conclusively. Additionally, several studies suggest that AMPK is involved in hypertrophic remodeling of the heart by influencing cardiac myocyte growth, a suggestion that remains controversial.
Hypothesis: AMPK mediates hypertrophic remodeling in response to pressure overload. Specifically, AMPK activation is a cellular signal responsible for accelerated rates of glycolysis in hypertrophied hearts. Additionally, AMPK influences myocardial structural remodeling and gene expression by limiting hypertrophic growth.
Experimental Approach: To test this hypothesis, H9c2 cells, derived from embryonic rat hearts, were treated with (1 µM) arginine vasopressin (AVP) to induce hypertrophy. Substrate utilization was measured and the effects of AMPK inhibition by either Compound C or by adenovirus-mediated transfer of dominant negative AMPK were determined. Subsequently, adenovirus-mediated transfer of constitutively active form of AMPK (CA-AMPK) was expressed in H9c2 to specifically increase AMPK activity and, thereby, further characterize the role of AMPK in hypertrophic remodeling.
Results: AVP induced a metabolic profile in hypertrophied H9c2 cells similar to that in intact hypertrophied hearts. Glycolysis was accelerated and palmitate oxidation was reduced with no significant alteration in glucose oxidation. These changes were associated with AMPK activation, and inhibition of AMPK ameliorated but did not normalize the hypertrophy-associated increase in glycolysis. CA-AMPK stimulated both glycolysis and fatty acid oxidation, and also increased protein synthesis and content. Howver, CA-AMPK did not induce a pathological hypertrophic phenotype as assessed by atrial natriuretic peptide expression.
Conclusion: Acceleration of glycolysis in AVP-treated hypertrophied heart muscle cells is partially dependent on AMPK. AMPK is a positive regulator of cell growth in these cells, but does not induce pathological hypertrophy when acting alone.
|
15 |
A NONLINEAR MODEL FOR GLYCOLYTIC OSCILLATIONS IN YEAST EXTRACTSSingh, Ajeet, 1942- January 1977 (has links)
No description available.
|
16 |
THE ROLE OF PURINES AND PYRIMIDINES IN BOVINE RED BLOOD CELL METABOLISMSeider, Michael John, 1951- January 1977 (has links)
No description available.
|
17 |
AMP-activated protein kinase and hypertrophic remodeling of heart muscle cellsSaeedi, Ramesh 05 1900 (has links)
Introduction: Cardiac hypertrophy is an adaptive response to increased myocardial workload that becomes maladaptive when hypertrophied hearts are exposed to an acute metabolic stress, such as ischemia/reperfusion. Acceleration of glycolysis occurs as part of the hypertrophic response and may be maladaptive because it enhances glycolytic metabolite accumulation and proton production. Activation of AMP-activated protein kinase (AMPK), a kinase involved in the regulation of energy metabolism, is proposed as a mechanism for the acceleration of glycolysis in hypertrophied hearts. However, this concept has not yet been proven conclusively. Additionally, several studies suggest that AMPK is involved in hypertrophic remodeling of the heart by influencing cardiac myocyte growth, a suggestion that remains controversial.
Hypothesis: AMPK mediates hypertrophic remodeling in response to pressure overload. Specifically, AMPK activation is a cellular signal responsible for accelerated rates of glycolysis in hypertrophied hearts. Additionally, AMPK influences myocardial structural remodeling and gene expression by limiting hypertrophic growth.
Experimental Approach: To test this hypothesis, H9c2 cells, derived from embryonic rat hearts, were treated with (1 µM) arginine vasopressin (AVP) to induce hypertrophy. Substrate utilization was measured and the effects of AMPK inhibition by either Compound C or by adenovirus-mediated transfer of dominant negative AMPK were determined. Subsequently, adenovirus-mediated transfer of constitutively active form of AMPK (CA-AMPK) was expressed in H9c2 to specifically increase AMPK activity and, thereby, further characterize the role of AMPK in hypertrophic remodeling.
Results: AVP induced a metabolic profile in hypertrophied H9c2 cells similar to that in intact hypertrophied hearts. Glycolysis was accelerated and palmitate oxidation was reduced with no significant alteration in glucose oxidation. These changes were associated with AMPK activation, and inhibition of AMPK ameliorated but did not normalize the hypertrophy-associated increase in glycolysis. CA-AMPK stimulated both glycolysis and fatty acid oxidation, and also increased protein synthesis and content. Howver, CA-AMPK did not induce a pathological hypertrophic phenotype as assessed by atrial natriuretic peptide expression.
Conclusion: Acceleration of glycolysis in AVP-treated hypertrophied heart muscle cells is partially dependent on AMPK. AMPK is a positive regulator of cell growth in these cells, but does not induce pathological hypertrophy when acting alone.
|
18 |
Glycolytic enzymes in human skeletal muscle following prolonged workCote, Richard William January 1975 (has links)
Previous studies have shown that ability to perform anaerobic activities is markedly reduced following prolonged exercise. It has been hypothesized that such changes are the result of reduced glycolytic capability. This study examined the changes in selected glycolytic enzyme activities in the leg muscles of men before, immediately after and 24 hours after prolonged exertion. Muscle biopsies obtained from the vastus lateralis were assayed for glycogen, total phosphorylase, lactate dehydrogenase (LDH), phosphofructokinase (PFK), and alpha glycerophosphate dehydrogenase ((GPDH). Muscle glycogen content was round to decrease significantly (P <.0l) from rest (116 mmoles/kg) Co post exercise (66 mmoles/kg), but 24 hours later it was only 15% lower than the pre exercise value. Phosphorylase and LDH increased significantly (+12.9% and +9.4%, respectively) as a result of the exercise. After 24 hours of rest phosphorylase returned to the pre exercise level, but LDH showed an additional increase of 6.2% in activity above the post exercise value. These data fail to support the hypothesis that prolonged severe exercise inhibits anaerobic capacity by reducing essential glycolytic enzymes.Supported by a grant for NIH (R0l AM17083-01).
|
19 |
A comparative proteomics approach to studying skeletal muscle mitochondria from myostatin knockout micePuddick, Jonathan. January 2006 (has links)
Thesis (M.Sc. Biological Sciences)--University of Waikato, 2006. / Title from PDF cover (viewed March 18, 2008) Includes bibliographical references (p. 98-112)
|
20 |
AMP-activated protein kinase, postmortem glycolysis, and PSE meatShen, Qingwu. January 2007 (has links)
Thesis (Ph. D.)--University of Wyoming, 2007. / Title from PDF title page (viewed on Dec. 5, 2008). Includes bibliographical references.
|
Page generated in 0.0298 seconds